Preferred Name |
Apatinib |
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C74012 |
code |
C74012 |
Concept_In_Subset | |
Contributing_Source |
CTRP |
DEFINITION |
An orally bioavailable, small-molecule receptor tyrosine kinase inhibitor with potential antiangiogenic and antineoplastic activities. Apatinib selectively binds to and inhibits vascular endothelial growth factor receptor 2, which may inhibit VEGF-stimulated endothelial cell migration and proliferation and decrease tumor microvessel density. In addition, this agent mildly inhibits c-Kit and c-SRC tyrosine kinases. |
Display_Name |
Apatinib |
FULL_SYN |
YN968D1 |
label |
Apatinib |
Legacy_Concept_Name |
Apatinib |
PDQ_Closed_Trial_Search_ID |
592508 |
PDQ_Open_Trial_Search_ID |
592508 |
Preferred_Name |
Apatinib |
prefixIRI |
C74012 |
prefLabel |
Apatinib |
Semantic_Type |
Pharmacologic Substance |
UMLS_CUI |
C2346836 |
subClassOf |
Delete | Mapping To | Ontology | Source |
---|---|---|---|
http://purl.bioontology.org/ontology/MESH/C553458 | Medical Subject Headings | LOOM |